Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

dsm-firmenich provides additional pro forma financial information for 2022 and 2023

This image opens in the lightbox

News provided by

dsm-firmenich

04 Oct, 2023, 05:00 GMT


KAISERAUGST, Switzerland and HEERLEN, Netherlands, Oct. 4, 2023 /PRNewswire/ -- dsm-firmenich, innovators in nutrition, health, and beauty, provides additional pro forma financial information for 2022 and 2023.

The historical pro forma financials are prepared as a combination of the historical figures reported by DSM N.V. and Firmenich SA.

The historical pro forma financials are unaudited and include estimates and approximations.

FY 2022 pro forma financials (updated as of October 4, 2023)


Net sales

2021

2022

2022

2022

2022

2022

2022

2022

(in € millions)

FY

Q1

Q2

H1

Q3

Q4

H2

FY

P&B


932

953

1,885

991

916

1,907

3,792

TTH


735

797

1,532

836

806

1,642

3,174

HNC


592

613

1,205

626

587

1,213

2,418

ANH


882

953

1,835

978

971

1,949

3,784

Corporate


21

19

40

15

15

30

70

dsm-firmenich

11,444

3,162

3,335

6,497

3,446

3,295

6,741

13,238










Adj. EBITDA

2021

2022

2022

2022

2022

2022

2022

2022

(in € millions)

FY

Q1

Q2

H1

Q3

Q4

H2

FY

P&B


201

164

365

217

166

383

748

TTH


135

136

271

141

137

278

549

HNC


126

142

268

144

121

265

533

ANH


155

158

313

116

95

211

524

Corporate


(22)

(18)

(40)

(19)

(20)

(39)

(79)

dsm-firmenich

2,200

595

582

1,177

599

499

1,098

2,275










Adj. EBITDA margin

2021

2022

2022

2022

2022

2022

2022

2022

( %)

FY

Q1

Q2

H1

Q3

Q4

H2

FY

P&B


21.6 %

17.2 %

19.4 %

21.9 %

18.1 %

20.1 %

19.7 %

TTH


18.4 %

17.1 %

17.7 %

16.9 %

17.0 %

16.9 %

17.3 %

HNC


21.3 %

23.2 %

22.2 %

23.0 %

20.6 %

21.8 %

22.0 %

ANH


17.6 %

16.6 %

17.1 %

11.9 %

9.8 %

10.8 %

13.8 %

Corporate









dsm-firmenich

19.2 %

18.8 %

17.5 %

18.1 %

17.4 %

15.1 %

16.3 %

17.2 %

Methodology

The 2022 pro forma financials are prepared as a combination of the historical figures reported by DSM N.V. and Firmenich SA.
The 2022 pro forma financials are unaudited and include estimates, including for example approximations due to the different reporting currencies. The reporting currency of dsm-firmenich is EUR.
The following reporting perimeter changes and adjustments are applied:
- Changes to the Business Units' reporting perimeters: combination of the units T&B and F&B in TTH; Personal Care & Aroma (PCA) transfer to P&B from HNC; other minor adjustments including the Consumer Healthcare business transfer from T&B to HNC.
- Intercompany profit elimination: HNC net sales were reduced by approximately €50m to eliminate ingredient sales to Firmenich.

Further information for the basis of preparation of the pro forma financials and related definitions can be found in the H1 2023 results press release.

FY 2022 pro forma EBITDA to Core Adjusted EPS walk



2022

2022

2022


H1

H2

FY





Sales

6,497

6,741

13,238





EBITDA

1,031

988

2,019

APMs

146

110

256





Adjusted EBITDA

1,177

1,098

2,275

Adjusted EBITDA %

18.1 %

16.3 %

17.2 %





D&A

(437)

(477)

(914)





EBIT

594

517

1,111

APMs

146

104

250





Adjusted EBIT

740

621

1,361





PPA

-

-

-





Core Adjusted EBIT

740

621

1,361





Fin ex

(66)

(93)

(159)





Core Adjusted PBT

674

528

1,202





Tax

(132)

(94)

(226)

Tax %

20 %

18 %

19 %





Share from associates

32

5

37





Core Adjusted Net profit

574

439

1,013





Non-controlling interest

8

9

17





Avg outstanding shares

264

265

265





Core Adjusted EPS

2.14

1.62

3.76

H1 2023 pro forma financials (updated as of October 4, 2023)


Net sales

2023

2023

2023

(in € millions)

Q1

Q2

H1

P&B

972

903

1,875

TTH

772

761

1,533

HNC

582

562

1,144

ANH

785

786

1,571

Corporate

11

18

29

dsm-firmenich

3,122

3,030

6,152





Adj. EBITDA

2023

2023

2023

(in € millions)

Q1

Q2

H1

P&B

210

169

379

TTH

152

137

289

HNC

120

100

220

ANH

68

17

85

Corporate

(29)

(15)

(44)

dsm-firmenich

521

408

929





Adj. EBITDA margin

2023

2023

2023

( %)

Q1

Q2

H1

P&B

21.6 %

18.7 %

20.2 %

TTH

19.7 %

18.0 %

18.9 %

HNC

20.6 %

17.8 %

19.2 %

ANH

8.7 %

2.2 %

5.4 %

Corporate




dsm-firmenich

16.7 %

13.5 %

15.1 %

About dsm-firmenich 
As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people.
www.dsm-firmenich.com 

For more information

Media
e-mail media@dsm-firmenich.com

Investors
e-mail investors@dsm-firmenich.com

Forward-looking statements
This press release may contain forward-looking statements with respect to dsm-firmenich's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of this press release prevails over other language versions.

Logo - https://mma.prnewswire.com/media/2071772/dsm_firmenich_Logo.jpg

Modal title

Also from this source

dsm-firmenich reports full year 2024 results

dsm-firmenich reports full year 2024 results

Management Report 2024 highlights Strategic plan executed: leading, innovation-focused consumer company in nutrition, health & beauty established...

dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion

dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion

dsm-firmenich, innovators in nutrition, health, and beauty, today announces the sale of its stake in the Feed Enzymes Alliance to its equal partner...

More Releases From This Source

Explore

Computer & Electronics

Computer & Electronics

Health Care & Hospitals

Health Care & Hospitals

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Supplementary Medicine

Supplementary Medicine

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.